ASTRAZEN

Received CDSCO Permission

received CDSCO permission to import and sell Durvalumab solution for endometrial cancer treatment, in combination with carboplatin and paclitaxel for adults with primary advanced or recurrent endometrial cancer. This follows a similar approval last month for its use in gastric cancer treatment.